FDA agrees that Ilaris can be used to treat three additional rare diseases

Three new indications have recently been approved for Ilaris (canakinumab) by the U.S. Food and Drug Administration (FDA), for adult and paediatric patients who are suffering from serious and rare auto-inflammatory diseases. Image Credit The diseases are Familial Mediterranean Fever (FMF), Hyperimmunoglobulin D Syndrome (HIDS) / Mevalonate Kinase Deficiency (MKD), and Tumor Necrosis Factor Receptor […]

Read more...
2

Business Security – Keeping an eye to a Spy

The progressive global economy of today is continuously giving challenges to businesses especially in security matters and this is visibly important and serious to deal with. It is recommended that businesses should provide time; effort and budget in securing their business from frauds, negligence, robbery and other critical incidence that would affect much the business. […]

Read more...